NCT00765375View on ClinicalTrials.gov

Safety and Efficacy of the Use of Botox on Acne

PHASE2TerminatedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Acne Vulgaris

Interventions

DRUG

Botulinum Neurotoxin Type A

1.5-3 units of Botox/lesion

DRUG

Bacteriostatic saline

.1 cc bacteriostatic saline/lesion

Trial Locations (1)

60611

DeNova Research, Chicago

Sponsors

Lead Sponsor

DeNova Research

All Listed Sponsors

lead

DeNova Research

OTHER

NCT00765375 - Safety and Efficacy of the Use of Botox on Acne | Biotech Hunter | Biotech Hunter